MIDDLE EAST PHARMACEUTICAL INDUSTRIES COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 128 SAR | +0.63% |
|
-4.05% | 0.00% |
| 05-19 | Avalon Pharma Swings to Profit in Q1; Revenue Down | MT |
| 05-06 | Avalon Pharma Secures Regulatory Nod for Second Production Facility in Saudi Arabia | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The Company develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Companyâs activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.
Sector
Pharmaceuticals
Sell
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
128
SAR
Average target price
107
SAR
Spread / Average Target
-16.41%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 678M | |
| +15.85% | 42.57B | |
| +19.34% | 21.01B | |
| +17.26% | 14.86B | |
| +17.68% | 14.47B | |
| +48.57% | 12.61B | |
| -0.05% | 6.79B | |
| -11.07% | 6.57B | |
| +14.13% | 5.62B | |
| +4.17% | 4.66B |
- Stock Market
- Equities
- 4016 Stock
- News Middle East Pharmaceutical Industries Company
- Avalon Pharma Secures Regulatory Nod for Second Production Facility in Saudi Arabia
